GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » PE Ratio

Decision Diagnostics (Decision Diagnostics) PE Ratio : At Loss (As of Apr. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Decision Diagnostics PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-04-29), Decision Diagnostics's share price is $0.0001. Decision Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.04. Therefore, Decision Diagnostics's PE Ratio for today is At Loss.

Decision Diagnostics's EPS (Diluted) for the three months ended in Sep. 2021 was $-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.04.

As of today (2024-04-29), Decision Diagnostics's share price is $0.0001. Decision Diagnostics's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.04. Therefore, Decision Diagnostics's PE Ratio without NRI ratio for today is At Loss.

Decision Diagnostics's EPS without NRI for the three months ended in Sep. 2021 was $-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.04.

Decision Diagnostics's EPS (Basic) for the three months ended in Sep. 2021 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.03.

Back to Basics: PE Ratio


Decision Diagnostics PE Ratio Historical Data

The historical data trend for Decision Diagnostics's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decision Diagnostics PE Ratio Chart

Decision Diagnostics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec17 Dec18 Dec19 Dec20
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Decision Diagnostics Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison of Decision Diagnostics's PE Ratio

For the Pharmaceutical Retailers subindustry, Decision Diagnostics's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decision Diagnostics's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Decision Diagnostics's PE Ratio distribution charts can be found below:

* The bar in red indicates where Decision Diagnostics's PE Ratio falls into.



Decision Diagnostics PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Decision Diagnostics's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=0.0001/-0.041
=-0(At Loss)

Decision Diagnostics's Share Price of today is $0.0001.
Decision Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Decision Diagnostics  (OTCPK:DECN) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Decision Diagnostics PE Ratio Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Decision Diagnostics (Decision Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.
Executives
Keith Berman director, officer: Secretary 2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich director 765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox director, officer: President

Decision Diagnostics (Decision Diagnostics) Headlines

From GuruFocus

DECN Comments on Recent Legal Filings by Federal Agencies

By ACCESSWIRE ACCESSWIRE 12-19-2020